ARCHIVES

Bristol-Myers Squibb Board Removes CEO Peter Dolan Over Plavix Deal. Two Republican Senators Say They Will Place Holds On Confirmation of Andrew von Eschenbach as FDA Commissioner. Craig Thompson Named Director of Abramson Cancer Center.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

MRI, 3D Ultrasound Combination Can Guide Prostate Biopsies

December 28, 2012

Congress Agrees On Jackson Lab Support, But does Not Add Money; Earmarks Hit NCI Budget

October 27, 1989

NCAB Subcommittee Works On Drafting Quantitative Risk Assessment Policy

October 1, 1982

Clinton Seeks Cut In NIH Increase

May 27, 1994

In Brief: On “Clouds Of glory,” And An Italian Bike, Varmus Takes Office As 14th NIH Director

November 26, 1993

Zeneca Says NSABP Was Tardy In Reporting Uterine Cancer Deaths

June 24, 1994